2:51 am

  Local News
  State / National / World
  Opinion / Letters
  Arts / Entertainment
  Submit Event
  Comics / Games
  DJ Designers
  Advertise With Us
  About Us
FDA approves clears new leukemia drug from Roche
November 02, 2013, 05:00 AM The Associated Press

WASHINGTON — The Food and Drug Administration on Friday approved a new drug from South San Francisco-based Roche to help treat patients with a type of cancer of the blood and bone marrow.

The agency cleared Gazyva to fight chronic lymphocytic leukemia in combination with chemotherapy in patients who haven’t previously been treated for the disease.

Gazyva works by killing cancer cells and encouraging the immune system to fight against them.

Chronic lymphocytic leukemia develops slowly over time and is usually diagnosed in the elderly. More than 15,600 Americans will be diagnosed and 4,580 of them will die from the disease this year, according to estimates from the National Cancer Institute.

The FDA approved the drug based on a study showing Gazyva plus chemotherapy was superior to chemotherapy alone at slowing the progress of the disease. Patients treated with Gazyva had median survival of 23 months before death, relapse or worsening of their disease. That compares with 11.1 months for the chemotherapy patients.

The injectable biotech drug is the first medicine approved under FDA’s breakthrough designation, which was authorized by Congress last year. The new designation is designed to speed up the approval of promising drugs by providing companies with extra meetings and earlier communication with FDA scientists to discuss drug development.

Gazyva will be marketed by Roche’s Genentech unit, which is based in South San Francisco.

A spokeswoman for Genentech said the drug would cost $41,300 for one course of treatment, which lasts six months.

Common side effects seen in company studies included anemia, fever, muscle and bone pain and lower levels of white blood cells.



Tags: gazyva, patients, chemotherapy, disease, cancer, approved,

Other stories from today:


Print this Page Print this Page  |  Bookmark and Share
<< Back
Return To Archives

Daily Journal Quick Poll
Do you agree with Gov. Brown signing The End of Life Option Act, which allows terminally ill patients to end their lives with the help of a doctor?

Yes, it will allow those with terminal conditions to die with dignity
No, doctors are sometimes too hasty in determining someone is terminally ill
Not sure


United States, 11 Pacific Rim countries reach trade deal
WASHINGTON — Having hammered out an ambitious trade deal with 11 Pacific Rim countries, the Obama ..
California governor signs right-to-die legislation
SACRAMENTO — Gov. Jerry Brown signed legislation Monday allowing terminally ill people in the nati..
US commander says Afghans requested US airstrike in Kunduz
WASHINGTON — Afghan forces who reported being under Taliban fire requested the U.S. airstrike that..
Three share Nobel medicine prize for tropical disease drugs
STOCKHOLM — A Chinese scientist who turned to ancient texts to discover a powerful malaria drug sh..
More >>  

©2015 San Mateo Daily Journal
San Mateo County order to show cause